@article{b41e1067fb5540b7ad73c584aedbf346,
title = "Temporary emergency guidance to STEMI systems of care during the COVID-19 pandemic: AHA's Mission: Lifeline",
keywords = "STEMI, percutaneous coronary intervention",
author = "\{On behalf of the American Heart Association's Mission: Lifeline and Get With The Guidelines Coronary Artery Disease Advisory Work Group and the Council on Clinical Cardiology's Committees on Acute Cardiac Care and General Cardiology and Interventional Cardiovascular Care\} and Jacobs, \{Alice K.\} and Murtuza Ali and Best, \{Patricia J.\} and Mark Bieniarz and Cohen, \{Mauricio G.\} and French, \{William J.\} and Fonarow, \{Gregg C.\} and Granger, \{Christopher B.\} and Abhinav Goyal and Henry, \{Timothy D.\} and Lori Hollowell and Hani Jneid and Jollis, \{James G.\} and Katz, \{Jason N.\} and Peter Mason and Venu Menon and Michael Redlener and Tamis-Holland, \{Jacqueline E.\} and Jessica Zegre-Hemsey",
note = "Funding Information: The Get With The Guidelines Coronary Artery Disease (GWTG-CAD) program is provided by the American Heart Association. GWTG-CAD is sponsored, in part, by Novartis, Edwards, and Amgen Cardiovascular. Dr Bieniarz reports consulting for Terumo and Abiomed, and consulting and speakers bureau for Amgen. Dr Fonarow reports consulting for Abbott, Amgen, AstraZeneca, Bayer, Edwards, Janssen, Medtronic, Merck, and Novartis. Dr Granger reports no conflicts relevant to the current work. Dr Jacobs is a site principal investigator for a trial by Abbott Vascular. Dr Z{\`e}gre-Hemsey receives funding through the US National Institutes of Health. Drs Ali, Best, Cohen, Goyal, Henry, Hollowell, Jneid, Jollis, Katz, Mason, Menon, Redlener, and Tamis-Holland have no relevant relationships to disclose.",
year = "2020",
month = jul,
day = "21",
doi = "10.1161/CIRCULATIONAHA.120.048180",
language = "English (US)",
volume = "142",
pages = "199--202",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}